MicroRNAs (miRs) have emerged as cardiovascular biomarkers and myocardial regulators with diagnostic and therapeutic potential.1,2 However, the miR profile of patients with hypertrophic cardiomyopathy (HCM) and miRs role in this genetic disease with heterogeneous phenotype3 are incompletely determined. Here a multi-step strategy provided evidence of differen- tially expressed miRs (DEmiRs) in plasma and myocardial tissue from HCM .
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy
Bertoli G;Rimoldi O;
2021
Abstract
MicroRNAs (miRs) have emerged as cardiovascular biomarkers and myocardial regulators with diagnostic and therapeutic potential.1,2 However, the miR profile of patients with hypertrophic cardiomyopathy (HCM) and miRs role in this genetic disease with heterogeneous phenotype3 are incompletely determined. Here a multi-step strategy provided evidence of differen- tially expressed miRs (DEmiRs) in plasma and myocardial tissue from HCM .File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Lombardi et a 2021.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
2.04 MB
Formato
Adobe PDF
|
2.04 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
